(Q43611502)

25 November 2017

title

Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro (English)

1 reference

25 November 2017

Sakuma S

1

1 reference

25 November 2017

Kato Y

2

1 reference

25 November 2017

Nishigaki F

3

1 reference

25 November 2017

Magari K

4

1 reference

25 November 2017

Miyata S

5

1 reference

25 November 2017

Ohkubo Y

6

1 reference

25 November 2017

Goto T

7

1 reference

25 November 2017

publication date

1 April 2001

1 reference

International Immunopharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

1

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

749-757

1 reference

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Anti-cytokine therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Biologic agents for treating rheumatoid arthritis. Concepts and progress

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Interleukin-6 and its receptor in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Effects of a novel immunosuppressive agent, FK506, on human B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

The effects of immunosuppressive agents on in vitro production of human immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

T cell-replacing factor for glucocorticosteroid-induced immunoglobulin production. A unique steroid-dependent cytokine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Independent regulation of B-cell inducing factor and IL-2 production by T lymphocytes, and direct and indirect promotion of immunoglobulin secretion by glucocorticosteroid

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Anti-inflammatory actions of glucocorticoids: molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Interleukin 6-induced differentiation of a human B cell line into IgM-secreting plasma cells is mediated by c-fos

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

SKW 6.4 cell differentiation induced by interleukin 6 is stimulated by butyrate

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Cytokine production in whole bloodex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Auranofin inhibits the induction of interleukin 1 beta and tumor necrosis factor alpha mRNA in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Human interleukin 6 and tumor necrosis factor alpha production studied at a single-cell level

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Molecular therapeutics. Methotrexate and its mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Immunologic studies of rheumatoid arthritis patients treated with methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

Therapeutic Drug Monitoring of Tacrolimus in Liver Transplantation, Phase III FK506 Multicenter Spanish Study Group: A Two-Year Follow-Up

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900008-X

7 January 2021

10.1016/S1567-5769(01)00008-X

Identifiers

DOI

1 reference

25 November 2017

1 reference